Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Background
Female infertility is characterized by a woman’s inability to become pregnant or maintain a pregnancy to its completion, even with consistent unprotected sexual intercourse over a prolonged period, usually around one year. This condition is multifaceted, with numerous potential factors contributing to its occurrence, and it can cause considerable emotional anguish for couples striving to achieve conception.
Extensive research conducted by the scientific community has established fecundability rates that serve as benchmarks for diagnosing infertility by determining normal pregnancy rates. Among the noteworthy studies, the largest one revealed that 85% of women would conceive within 12 months. According to this study, the fecundability rate is 25% during the initial three months of unprotected intercourse, declining to 15% for the subsequent nine months.
Epidemiology
Age-related factors play a role in declining female fertility as the reproductive system naturally ages. Women in their early 20s typically experience the highest fertility rates, which gradually decrease after age of 30.
However, the decline becomes notably more significant after the age of 35, with a sharp drop occurring beyond the age of 40.
Female infertility often occurs from ovulatory disorders, which can impede regular ovulation.
Conditions including hormonal imbalances, polycystic ovary syndrome, thyroid disorders, and specific chronic ailments can disrupt the ovulation process.
Anatomy
Pathophysiology
The occurrence of normal ovulation is essential for fertility. Disruptions in the hypothalamic-pituitary-ovarian axis can cause irregular or absent ovulation. Conditions such as polycystic ovary syndrome (PCOS), hypothalamic dysfunction, and premature ovarian failure can result in ovulatory dysfunction, leading to infertility.
Blockages or structural abnormalities in the fallopian tubes can hinder the egg’s journey or prevent successful fertilization. Conditions including pelvic inflammatory disease, endometriosis, or previous pelvic surgeries can cause damage to the fallopian tubes.
Structural irregularities, such as uterine fibroids, polyps, congenital malformations (like a septate uterus), or intrauterine adhesions (known as Asherman’s syndrome), can hinder implantation and increase the likelihood of recurrent pregnancy loss.
Issues with cervical mucus production, infections, or cervical stenosis can impede the penetration of sperm through the cervix and into the uterus.
The endometrium, which lines the uterus, undergoes cyclical changes during the menstrual cycle to support implantation. Conditions such as endometriosis, adenomyosis, or chronic endometritis can disrupt the normal development of the endometrium, leading to difficulties in implantation and reduced fertility.
Maintaining proper hormonal balance is crucial for normal reproductive function. Hormonal disorders like polycystic ovary syndrome (PCOS), thyroid dysfunction, hyperprolactinemia, or hypothalamic dysfunction can disrupt ovulation, hinder follicle development, or disturb the endometrial environment, thus affecting fertility.
Etiology
To identify the gender distribution and causes of infertility, the World Health Organisation (WHO) conducted a significant multinational study.
According to the study, the distribution of infertility causes among couples is as follows:
Now, focusing on the identifiable factors of female infertility, the study identified the following as the most common causes:
Genetics
Prognostic Factors
Pregnancy rates were collected from a retrospective analysis of 45 separate studies. The success rates of various fertility treatments can vary significantly.
Clinical History
Age Group:
As women approach their mid to late thirties, fertility begins to decline gradually. The quality and quantity of eggs decrease, which can make it more challenging to conceive. However, many women in this age range can still become pregnant naturally, although it may take longer.
Advanced maternal age, typically defined as 35 or 40 years and older, is associated with a significant decline in fertility. The quality and quantity of eggs further decrease, making it more difficult to conceive naturally.
History:
Obstetrical history: This involves assessing the woman’s previous pregnancies, including any complications, miscarriages, or preterm births.
Duration of infertility: Determining how long the couple has been trying to conceive helps in understanding the duration of their fertility challenges.
Menstrual history, including molimina: Gathering information about the woman’s menstrual cycles, such as regularity, length, and symptoms (such as premenstrual syndrome or molimina), helps identify potential issues related to ovulation and hormonal balance.
Family history and genetic screening: Inquiring about the couple’s family history can help identify any genetic disorders or inherited conditions that may contribute to infertility. Additionally, assessing the history of venous thrombotic events, recurrent pregnancy loss, and infertility within the family can provide valuable insights.
Male partner evaluation: Assessing the male partner’s sexual health is crucial, including issues related to erection and ejaculation, as they may impact fertility.
Sexual history: Inquiring about the couple’s sexual activity, including coital frequency and timing in relation to the woman’s menstrual cycle, helps determine if they are engaging in intercourse during the most fertile window.
Medical, surgical, and gynecological history: Understanding the individual’s medical history, including any past surgeries, gynecological issues, and sexually transmitted infections (STIs), can provide insight into potential causes of infertility.
Social and lifestyle history: Inquiring about lifestyle factors such as smoking, alcohol consumption, illicit drug use, exercise habits, and diet helps identify potential factors that may affect fertility. Occupational factors that could contribute to infertility may also be discussed.
Physical Examination
Physical Examination:
Age group
Associated comorbidity
Polycystic ovary syndrome (PCOS) is a condition characterized by hormonal imbalances affecting women in their reproductive years. It can result in irregular or absent ovulation, leading to difficulties in conceiving.
Structural abnormalities of the uterus, such as uterine fibroids, polyps, or congenital malformations, can impede implantation or hinder the ability to sustain a pregnancy to full term.
Associated activity
Acuity of presentation
Women with infertility issues may have irregular or absent menstrual cycles. This can indicate problems with ovulation, hormonal imbalances, or conditions such as polycystic ovary syndrome (PCOS).
Hormonal imbalances can disrupt the normal reproductive processes. Symptoms like excessive facial or body hair growth (hirsutism), acne, or weight gain can indicate hormonal disorders like PCOS.
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
The treatment paradigm for female infertility varies depending on the underlying cause and individual factors.
Ovulatory disorders:
Endometriosis:
Pelvic adhesions:
Tubal blockage:
Hyperprolactinemia:
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
high-body-weight-modulation
High body weight, particularly obesity, can indeed have a significant impact on female fertility. Obesity is defined as having a body mass index (BMI) of 30 or higher. It can lead to hormonal imbalances and interfere with reproductive processes, making it more challenging for women to conceive.
Healthy diet: Adopting a balanced and nutritious diet, rich in fruits, vegetables, whole grains, lean proteins, and healthy fats, can support weight loss and overall reproductive health.
Regular exercise: Engaging in regular physical activity can aid in weight loss, improve insulin sensitivity, and promote hormonal balance. Consult with a healthcare professional to develop an exercise plan suitable for your individual needs.
Lifestyle modifications: Making healthy lifestyle choices such as reducing stress, getting adequate sleep, and avoiding smoking and excessive alcohol consumption can also support weight loss efforts and enhance fertility.
low-body-weight-modulation
Low body weight can indeed have an impact on female fertility. Maintaining a healthy weight is important for reproductive health, and underweight conditions can affect a woman’s ability to conceive.
Anovulation refers to the absence of ovulation, which is necessary for conception. Low body weight, particularly in cases of extreme or rapid weight loss, can disrupt the normal hormonal signaling required for ovulation to occur.
As a result, women may experience irregular or infrequent ovulation or even a complete absence of ovulation.
Achieve a healthy weight: Focus on reaching a healthy weight range for your height and body type. This often involves gaining weight to achieve a BMI (body mass index) within the normal range (18.5 to 24.9). A healthcare professional can help determine the appropriate target weight for you.
Balanced and nutritious diet: Ensure that your diet provides adequate nutrition to support reproductive health. Include a variety of nutrient-dense foods such as fruits, vegetables, whole grains, lean proteins, and healthy fats. Working with a registered dietitian can be beneficial in creating a well-rounded meal plan that meets your specific needs.
Caloric intake: If you have been under-consuming calories due to low body weight, gradually increase your calorie intake to support weight gain. However, it’s important to do this in a balanced manner and avoid excessive or rapid weight gain, as it can also have negative impacts on fertility.
Exercise moderation: Engage in regular, moderate exercise that supports overall health without excessive strain or intensity. Exercise can help maintain a healthy weight, promote hormonal balance, and enhance fertility. However, excessive exercise or intense training can disrupt menstrual cycles and affect fertility, so it’s important to find a balance that works for you.
Stress management: Chronic stress can impact fertility. Incorporate stress-management techniques such as mindfulness, meditation, yoga, or counseling to help reduce stress levels and support overall well-being.
Use of Ovulation Induction Agents for Female Infertility
clomiphene citrate (Clomid):
Clomid is an oral medication that acts as a selective estrogen receptor modulator (SERM). It blocks estrogen receptors in the hypothalamus, which tricks the body into perceiving low estrogen levels.
As a result, the hypothalamus releases more gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to produce more follicle-stimulating hormone (FSH).
Increased FSH levels encourage the growth and maturation of ovarian follicles, leading to ovulation.
Clomid is commonly used at low doses to induce the growth of a single follicle and promote the release of a single egg.
letrozole (Femara):
letrozole is an oral drug used for ovulation induction. It belongs to a class of drugs called aromatase inhibitors, which work by reducing the production of estrogen. Lower estrogen levels stimulate the hypothalamus to release more GnRH and subsequently increase FSH production.
letrozole has been found to be particularly effective in women with polycystic ovary syndrome (PCOS), making it the first-line choice for ovulation induction in this population.
Letrozole should be prioritized as the primary treatment option for women diagnosed with PCOS instead of clomiphene. The advantages of letrozole compared to clomiphene include.
Studies have shown that Letrozole may have advantages over Clomid in terms of higher ovulation and pregnancy rates in women with PCOS.
Use of Gonadotropin Therapy for Certain Types of Female Infertility
Gonadotropins (Menopur, Gonal-F, Follistim):
Gonadotropins are injectable medications that contain either FSH alone or a combination of FSH and luteinizing hormone (LH). These drugs are more potent than oral agents like Clomid and Letrozole.
Gonadotropins are typically used in cases where Clomid or Letrozole have not been effective or in situations where a higher number of follicles need to be stimulated for superovulation. They can be administered alone or in combination with oral medications.
It involves the use of medications that contain follicle-stimulating hormone (FSH) and luteinizing hormone (LH) to stimulate the ovaries and promote the development and release of eggs.
In a specific study involving normogonadotropic anovulatory women who failed to achieve pregnancy after undergoing six cycles of clomiphene citrate therapy, it was observed that subsequent administration of gonadotropins resulted in a higher rate of live births compared to continuing treatment with clomiphene (52% versus 41%).
Close monitoring is essential when using gonadotropins, usually through ultrasound imaging and estrogen measurements, to assess ovarian response and minimize the risk of complications.
Use of Other agents for PCOS
metformin:
Insulin resistance is frequently observed in females diagnosed with polycystic ovary syndrome (PCOS). Administering metformin to correct hyperinsulinemia proves advantageous for anovulatory women with PCOS, as it promotes improved menstrual regularity and increased likelihood of spontaneous ovulation. Nevertheless, it is worth noting that the success rates in terms of live births are not as remarkable as those achieved with clomiphene
Use of Laparoscopic Surgery
Laparoscopic surgery used to diagnose and treat various conditions, including female infertility. It involves making small incisions in the abdomen and inserting a laparoscope—a thin, flexible tube with a camera and surgical instruments—to visualize and operate on the reproductive organs. It helps in identifying Endometriosis, ovarian cysts and Uterine abnormalities.
Use and Effectiveness of dopamine Agonists in Hyperprolactinemic Anovulation
Dopamine agonists, such as bromocriptine and cabergoline, are commonly used as the first-line treatment for hyperprolactinemia, including cases associated with pituitary adenomas. These medications work by reducing the production of prolactin, a hormone that can inhibit ovulation and fertility.
The efficacy of dopamine agonists in treating hyperprolactinemia has been well-established. Even in the presence of pituitary adenomas, these drugs have shown effectiveness in reducing prolactin levels and restoring normal ovulatory cycles.
In patients with hyperprolactinemic anovulation, long-term use of dopamine agonists can have positive effects on fertility. By reducing prolactin levels, these medications can help promote the occurrence of spontaneous ovulatory cycles. They can also normalize the luteal phase, which is important for successful implantation and early pregnancy.
Use of Tubal and Pelvic Adhesions in IVF
In cases of bilateral tubal factor infertility, in vitro fertilization (IVF) is the recommended primary treatment option. Alternative procedures such as tubal corrective surgeries have demonstrated poorer pregnancy outcomes and an elevated risk of ectopic pregnancy. In situations where women experience severe tubal disease, including hydrosalpinx, it is advised to undergo a bilateral salpingectomy to enhance the success rate of IVF and improve the chances of pregnancy. However, for individuals with mild distal tubal disease, fimbrioplasty may be considered as an alternative, enabling multiple pregnancies without the need for IVF.
It is important to note that a small-scale study indicated comparable pregnancy rates to IVF in cases of mild tubal disease, yet there was a significantly higher risk of ectopic pregnancy (15%) compared to the minimal risk (0.7%) associated with IVF treatment.
Medication
250
mcg
Subcutaneous (SC)
daily
during the mid-to-late phase of the cycle after starting follicle-stimulating hormone (FSH) on day 2 or 3 of the cycle
Single dosage regimen: use 3 mg Subcutaneously When serum estradiol levels show proper stimulation response (with a range day 5-9), generally day 7; if hCG is not given within four days, use 0.25 mg/day till hCG is administered
Multiple dosage regimen: use 3 mg Subcutaneously morning or evening on stimulation day 5 and morning for stimulation day 6; continue till hCG is administered
Dose Adjustments
Dosing modifications
Renal Impairment
Mild-moderate: Dose adjustment is not necessary
Severe: Contraindicated
Hepatic Impairment
Dose adjustment is not necessary
Indicated for Multifollicular development in assisted reproductive technologies
:
Individual daily dosages for the first treatment cycle are determined by body weight and plasma anti-Mullerian hormone (AMH) concentrations.
The first treatment cycle is
AMH <15 pmol/L: Administer 12 mcg/day (regardless of body weight).
AMH >15 pmol/L: Dosage depends on AMH levels
The maximum daily dosage is 12 mcg.
Increasing AMH levels reduces the recommended daily dose from 0.19 to 0.1 mcg/kg.
air polymer type A intrauterine deviceÂ
It is used as a contrast agent for imaging sonohysterosalpingography to detect ectopic pregnancy in women with suspected infertility
2-3 ml infusion through the intrauterine route
Repeat by 2-3 ml as required to visualize the fallopian tube
Do not exceed the total dose of more than 10 ml
Do not continue the diagnosis without confirming any pregnancy
Indicated for Fertility problems
Age <36 years
Body weight <60 Kg: A single 100 mcg subcutaneous dose is suggested
Age >36 years
Body weight >50 Kg: A single 150 mcg subcutaneous dose is suggested
Age >36 years
Body weight <50 Kg: Safety and efficacy not established
Take a dose of 50 mg orally once daily
500 - 1000
mg
Tablet
Orally 
once a day
3
months
2
mg
Suppository
Intravaginal
once a day
3
days
10mg orally once daily from the 14th to the 25th day of the cycle for six months
10mg or 20mg orally once daily should be taken during 2nd half of the menstrual phase until 1st day of the next cycle
Indications: it is indicated to treat infertility due to luteal insufficiency
75 IU SC Once daily for 12 days
Future Trends
Female infertility is characterized by a woman’s inability to become pregnant or maintain a pregnancy to its completion, even with consistent unprotected sexual intercourse over a prolonged period, usually around one year. This condition is multifaceted, with numerous potential factors contributing to its occurrence, and it can cause considerable emotional anguish for couples striving to achieve conception.
Extensive research conducted by the scientific community has established fecundability rates that serve as benchmarks for diagnosing infertility by determining normal pregnancy rates. Among the noteworthy studies, the largest one revealed that 85% of women would conceive within 12 months. According to this study, the fecundability rate is 25% during the initial three months of unprotected intercourse, declining to 15% for the subsequent nine months.
Age-related factors play a role in declining female fertility as the reproductive system naturally ages. Women in their early 20s typically experience the highest fertility rates, which gradually decrease after age of 30.
However, the decline becomes notably more significant after the age of 35, with a sharp drop occurring beyond the age of 40.
Female infertility often occurs from ovulatory disorders, which can impede regular ovulation.
Conditions including hormonal imbalances, polycystic ovary syndrome, thyroid disorders, and specific chronic ailments can disrupt the ovulation process.
The occurrence of normal ovulation is essential for fertility. Disruptions in the hypothalamic-pituitary-ovarian axis can cause irregular or absent ovulation. Conditions such as polycystic ovary syndrome (PCOS), hypothalamic dysfunction, and premature ovarian failure can result in ovulatory dysfunction, leading to infertility.
Blockages or structural abnormalities in the fallopian tubes can hinder the egg’s journey or prevent successful fertilization. Conditions including pelvic inflammatory disease, endometriosis, or previous pelvic surgeries can cause damage to the fallopian tubes.
Structural irregularities, such as uterine fibroids, polyps, congenital malformations (like a septate uterus), or intrauterine adhesions (known as Asherman’s syndrome), can hinder implantation and increase the likelihood of recurrent pregnancy loss.
Issues with cervical mucus production, infections, or cervical stenosis can impede the penetration of sperm through the cervix and into the uterus.
The endometrium, which lines the uterus, undergoes cyclical changes during the menstrual cycle to support implantation. Conditions such as endometriosis, adenomyosis, or chronic endometritis can disrupt the normal development of the endometrium, leading to difficulties in implantation and reduced fertility.
Maintaining proper hormonal balance is crucial for normal reproductive function. Hormonal disorders like polycystic ovary syndrome (PCOS), thyroid dysfunction, hyperprolactinemia, or hypothalamic dysfunction can disrupt ovulation, hinder follicle development, or disturb the endometrial environment, thus affecting fertility.
To identify the gender distribution and causes of infertility, the World Health Organisation (WHO) conducted a significant multinational study.
According to the study, the distribution of infertility causes among couples is as follows:
Now, focusing on the identifiable factors of female infertility, the study identified the following as the most common causes:
Pregnancy rates were collected from a retrospective analysis of 45 separate studies. The success rates of various fertility treatments can vary significantly.
Age Group:
As women approach their mid to late thirties, fertility begins to decline gradually. The quality and quantity of eggs decrease, which can make it more challenging to conceive. However, many women in this age range can still become pregnant naturally, although it may take longer.
Advanced maternal age, typically defined as 35 or 40 years and older, is associated with a significant decline in fertility. The quality and quantity of eggs further decrease, making it more difficult to conceive naturally.
History:
Obstetrical history: This involves assessing the woman’s previous pregnancies, including any complications, miscarriages, or preterm births.
Duration of infertility: Determining how long the couple has been trying to conceive helps in understanding the duration of their fertility challenges.
Menstrual history, including molimina: Gathering information about the woman’s menstrual cycles, such as regularity, length, and symptoms (such as premenstrual syndrome or molimina), helps identify potential issues related to ovulation and hormonal balance.
Family history and genetic screening: Inquiring about the couple’s family history can help identify any genetic disorders or inherited conditions that may contribute to infertility. Additionally, assessing the history of venous thrombotic events, recurrent pregnancy loss, and infertility within the family can provide valuable insights.
Male partner evaluation: Assessing the male partner’s sexual health is crucial, including issues related to erection and ejaculation, as they may impact fertility.
Sexual history: Inquiring about the couple’s sexual activity, including coital frequency and timing in relation to the woman’s menstrual cycle, helps determine if they are engaging in intercourse during the most fertile window.
Medical, surgical, and gynecological history: Understanding the individual’s medical history, including any past surgeries, gynecological issues, and sexually transmitted infections (STIs), can provide insight into potential causes of infertility.
Social and lifestyle history: Inquiring about lifestyle factors such as smoking, alcohol consumption, illicit drug use, exercise habits, and diet helps identify potential factors that may affect fertility. Occupational factors that could contribute to infertility may also be discussed.
Physical Examination:
Polycystic ovary syndrome (PCOS) is a condition characterized by hormonal imbalances affecting women in their reproductive years. It can result in irregular or absent ovulation, leading to difficulties in conceiving.
Structural abnormalities of the uterus, such as uterine fibroids, polyps, or congenital malformations, can impede implantation or hinder the ability to sustain a pregnancy to full term.
Women with infertility issues may have irregular or absent menstrual cycles. This can indicate problems with ovulation, hormonal imbalances, or conditions such as polycystic ovary syndrome (PCOS).
Hormonal imbalances can disrupt the normal reproductive processes. Symptoms like excessive facial or body hair growth (hirsutism), acne, or weight gain can indicate hormonal disorders like PCOS.
The treatment paradigm for female infertility varies depending on the underlying cause and individual factors.
Ovulatory disorders:
Endometriosis:
Pelvic adhesions:
Tubal blockage:
Hyperprolactinemia:
Endocrinology, Reproductive/Infertility
Nutrition
OB/GYN and Women\'s Health
High body weight, particularly obesity, can indeed have a significant impact on female fertility. Obesity is defined as having a body mass index (BMI) of 30 or higher. It can lead to hormonal imbalances and interfere with reproductive processes, making it more challenging for women to conceive.
Healthy diet: Adopting a balanced and nutritious diet, rich in fruits, vegetables, whole grains, lean proteins, and healthy fats, can support weight loss and overall reproductive health.
Regular exercise: Engaging in regular physical activity can aid in weight loss, improve insulin sensitivity, and promote hormonal balance. Consult with a healthcare professional to develop an exercise plan suitable for your individual needs.
Lifestyle modifications: Making healthy lifestyle choices such as reducing stress, getting adequate sleep, and avoiding smoking and excessive alcohol consumption can also support weight loss efforts and enhance fertility.
Endocrinology, Reproductive/Infertility
Nutrition
OB/GYN and Women\'s Health
Low body weight can indeed have an impact on female fertility. Maintaining a healthy weight is important for reproductive health, and underweight conditions can affect a woman’s ability to conceive.
Anovulation refers to the absence of ovulation, which is necessary for conception. Low body weight, particularly in cases of extreme or rapid weight loss, can disrupt the normal hormonal signaling required for ovulation to occur.
As a result, women may experience irregular or infrequent ovulation or even a complete absence of ovulation.
Achieve a healthy weight: Focus on reaching a healthy weight range for your height and body type. This often involves gaining weight to achieve a BMI (body mass index) within the normal range (18.5 to 24.9). A healthcare professional can help determine the appropriate target weight for you.
Balanced and nutritious diet: Ensure that your diet provides adequate nutrition to support reproductive health. Include a variety of nutrient-dense foods such as fruits, vegetables, whole grains, lean proteins, and healthy fats. Working with a registered dietitian can be beneficial in creating a well-rounded meal plan that meets your specific needs.
Caloric intake: If you have been under-consuming calories due to low body weight, gradually increase your calorie intake to support weight gain. However, it’s important to do this in a balanced manner and avoid excessive or rapid weight gain, as it can also have negative impacts on fertility.
Exercise moderation: Engage in regular, moderate exercise that supports overall health without excessive strain or intensity. Exercise can help maintain a healthy weight, promote hormonal balance, and enhance fertility. However, excessive exercise or intense training can disrupt menstrual cycles and affect fertility, so it’s important to find a balance that works for you.
Stress management: Chronic stress can impact fertility. Incorporate stress-management techniques such as mindfulness, meditation, yoga, or counseling to help reduce stress levels and support overall well-being.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
clomiphene citrate (Clomid):
Clomid is an oral medication that acts as a selective estrogen receptor modulator (SERM). It blocks estrogen receptors in the hypothalamus, which tricks the body into perceiving low estrogen levels.
As a result, the hypothalamus releases more gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to produce more follicle-stimulating hormone (FSH).
Increased FSH levels encourage the growth and maturation of ovarian follicles, leading to ovulation.
Clomid is commonly used at low doses to induce the growth of a single follicle and promote the release of a single egg.
letrozole (Femara):
letrozole is an oral drug used for ovulation induction. It belongs to a class of drugs called aromatase inhibitors, which work by reducing the production of estrogen. Lower estrogen levels stimulate the hypothalamus to release more GnRH and subsequently increase FSH production.
letrozole has been found to be particularly effective in women with polycystic ovary syndrome (PCOS), making it the first-line choice for ovulation induction in this population.
Letrozole should be prioritized as the primary treatment option for women diagnosed with PCOS instead of clomiphene. The advantages of letrozole compared to clomiphene include.
Studies have shown that Letrozole may have advantages over Clomid in terms of higher ovulation and pregnancy rates in women with PCOS.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
Gonadotropins (Menopur, Gonal-F, Follistim):
Gonadotropins are injectable medications that contain either FSH alone or a combination of FSH and luteinizing hormone (LH). These drugs are more potent than oral agents like Clomid and Letrozole.
Gonadotropins are typically used in cases where Clomid or Letrozole have not been effective or in situations where a higher number of follicles need to be stimulated for superovulation. They can be administered alone or in combination with oral medications.
It involves the use of medications that contain follicle-stimulating hormone (FSH) and luteinizing hormone (LH) to stimulate the ovaries and promote the development and release of eggs.
In a specific study involving normogonadotropic anovulatory women who failed to achieve pregnancy after undergoing six cycles of clomiphene citrate therapy, it was observed that subsequent administration of gonadotropins resulted in a higher rate of live births compared to continuing treatment with clomiphene (52% versus 41%).
Close monitoring is essential when using gonadotropins, usually through ultrasound imaging and estrogen measurements, to assess ovarian response and minimize the risk of complications.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
metformin:
Insulin resistance is frequently observed in females diagnosed with polycystic ovary syndrome (PCOS). Administering metformin to correct hyperinsulinemia proves advantageous for anovulatory women with PCOS, as it promotes improved menstrual regularity and increased likelihood of spontaneous ovulation. Nevertheless, it is worth noting that the success rates in terms of live births are not as remarkable as those achieved with clomiphene
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
Laparoscopic surgery used to diagnose and treat various conditions, including female infertility. It involves making small incisions in the abdomen and inserting a laparoscope—a thin, flexible tube with a camera and surgical instruments—to visualize and operate on the reproductive organs. It helps in identifying Endometriosis, ovarian cysts and Uterine abnormalities.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
Dopamine agonists, such as bromocriptine and cabergoline, are commonly used as the first-line treatment for hyperprolactinemia, including cases associated with pituitary adenomas. These medications work by reducing the production of prolactin, a hormone that can inhibit ovulation and fertility.
The efficacy of dopamine agonists in treating hyperprolactinemia has been well-established. Even in the presence of pituitary adenomas, these drugs have shown effectiveness in reducing prolactin levels and restoring normal ovulatory cycles.
In patients with hyperprolactinemic anovulation, long-term use of dopamine agonists can have positive effects on fertility. By reducing prolactin levels, these medications can help promote the occurrence of spontaneous ovulatory cycles. They can also normalize the luteal phase, which is important for successful implantation and early pregnancy.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
In cases of bilateral tubal factor infertility, in vitro fertilization (IVF) is the recommended primary treatment option. Alternative procedures such as tubal corrective surgeries have demonstrated poorer pregnancy outcomes and an elevated risk of ectopic pregnancy. In situations where women experience severe tubal disease, including hydrosalpinx, it is advised to undergo a bilateral salpingectomy to enhance the success rate of IVF and improve the chances of pregnancy. However, for individuals with mild distal tubal disease, fimbrioplasty may be considered as an alternative, enabling multiple pregnancies without the need for IVF.
It is important to note that a small-scale study indicated comparable pregnancy rates to IVF in cases of mild tubal disease, yet there was a significantly higher risk of ectopic pregnancy (15%) compared to the minimal risk (0.7%) associated with IVF treatment.
Female infertility is characterized by a woman’s inability to become pregnant or maintain a pregnancy to its completion, even with consistent unprotected sexual intercourse over a prolonged period, usually around one year. This condition is multifaceted, with numerous potential factors contributing to its occurrence, and it can cause considerable emotional anguish for couples striving to achieve conception.
Extensive research conducted by the scientific community has established fecundability rates that serve as benchmarks for diagnosing infertility by determining normal pregnancy rates. Among the noteworthy studies, the largest one revealed that 85% of women would conceive within 12 months. According to this study, the fecundability rate is 25% during the initial three months of unprotected intercourse, declining to 15% for the subsequent nine months.
Age-related factors play a role in declining female fertility as the reproductive system naturally ages. Women in their early 20s typically experience the highest fertility rates, which gradually decrease after age of 30.
However, the decline becomes notably more significant after the age of 35, with a sharp drop occurring beyond the age of 40.
Female infertility often occurs from ovulatory disorders, which can impede regular ovulation.
Conditions including hormonal imbalances, polycystic ovary syndrome, thyroid disorders, and specific chronic ailments can disrupt the ovulation process.
The occurrence of normal ovulation is essential for fertility. Disruptions in the hypothalamic-pituitary-ovarian axis can cause irregular or absent ovulation. Conditions such as polycystic ovary syndrome (PCOS), hypothalamic dysfunction, and premature ovarian failure can result in ovulatory dysfunction, leading to infertility.
Blockages or structural abnormalities in the fallopian tubes can hinder the egg’s journey or prevent successful fertilization. Conditions including pelvic inflammatory disease, endometriosis, or previous pelvic surgeries can cause damage to the fallopian tubes.
Structural irregularities, such as uterine fibroids, polyps, congenital malformations (like a septate uterus), or intrauterine adhesions (known as Asherman’s syndrome), can hinder implantation and increase the likelihood of recurrent pregnancy loss.
Issues with cervical mucus production, infections, or cervical stenosis can impede the penetration of sperm through the cervix and into the uterus.
The endometrium, which lines the uterus, undergoes cyclical changes during the menstrual cycle to support implantation. Conditions such as endometriosis, adenomyosis, or chronic endometritis can disrupt the normal development of the endometrium, leading to difficulties in implantation and reduced fertility.
Maintaining proper hormonal balance is crucial for normal reproductive function. Hormonal disorders like polycystic ovary syndrome (PCOS), thyroid dysfunction, hyperprolactinemia, or hypothalamic dysfunction can disrupt ovulation, hinder follicle development, or disturb the endometrial environment, thus affecting fertility.
To identify the gender distribution and causes of infertility, the World Health Organisation (WHO) conducted a significant multinational study.
According to the study, the distribution of infertility causes among couples is as follows:
Now, focusing on the identifiable factors of female infertility, the study identified the following as the most common causes:
Pregnancy rates were collected from a retrospective analysis of 45 separate studies. The success rates of various fertility treatments can vary significantly.
Age Group:
As women approach their mid to late thirties, fertility begins to decline gradually. The quality and quantity of eggs decrease, which can make it more challenging to conceive. However, many women in this age range can still become pregnant naturally, although it may take longer.
Advanced maternal age, typically defined as 35 or 40 years and older, is associated with a significant decline in fertility. The quality and quantity of eggs further decrease, making it more difficult to conceive naturally.
History:
Obstetrical history: This involves assessing the woman’s previous pregnancies, including any complications, miscarriages, or preterm births.
Duration of infertility: Determining how long the couple has been trying to conceive helps in understanding the duration of their fertility challenges.
Menstrual history, including molimina: Gathering information about the woman’s menstrual cycles, such as regularity, length, and symptoms (such as premenstrual syndrome or molimina), helps identify potential issues related to ovulation and hormonal balance.
Family history and genetic screening: Inquiring about the couple’s family history can help identify any genetic disorders or inherited conditions that may contribute to infertility. Additionally, assessing the history of venous thrombotic events, recurrent pregnancy loss, and infertility within the family can provide valuable insights.
Male partner evaluation: Assessing the male partner’s sexual health is crucial, including issues related to erection and ejaculation, as they may impact fertility.
Sexual history: Inquiring about the couple’s sexual activity, including coital frequency and timing in relation to the woman’s menstrual cycle, helps determine if they are engaging in intercourse during the most fertile window.
Medical, surgical, and gynecological history: Understanding the individual’s medical history, including any past surgeries, gynecological issues, and sexually transmitted infections (STIs), can provide insight into potential causes of infertility.
Social and lifestyle history: Inquiring about lifestyle factors such as smoking, alcohol consumption, illicit drug use, exercise habits, and diet helps identify potential factors that may affect fertility. Occupational factors that could contribute to infertility may also be discussed.
Physical Examination:
Polycystic ovary syndrome (PCOS) is a condition characterized by hormonal imbalances affecting women in their reproductive years. It can result in irregular or absent ovulation, leading to difficulties in conceiving.
Structural abnormalities of the uterus, such as uterine fibroids, polyps, or congenital malformations, can impede implantation or hinder the ability to sustain a pregnancy to full term.
Women with infertility issues may have irregular or absent menstrual cycles. This can indicate problems with ovulation, hormonal imbalances, or conditions such as polycystic ovary syndrome (PCOS).
Hormonal imbalances can disrupt the normal reproductive processes. Symptoms like excessive facial or body hair growth (hirsutism), acne, or weight gain can indicate hormonal disorders like PCOS.
The treatment paradigm for female infertility varies depending on the underlying cause and individual factors.
Ovulatory disorders:
Endometriosis:
Pelvic adhesions:
Tubal blockage:
Hyperprolactinemia:
Endocrinology, Reproductive/Infertility
Nutrition
OB/GYN and Women\'s Health
High body weight, particularly obesity, can indeed have a significant impact on female fertility. Obesity is defined as having a body mass index (BMI) of 30 or higher. It can lead to hormonal imbalances and interfere with reproductive processes, making it more challenging for women to conceive.
Healthy diet: Adopting a balanced and nutritious diet, rich in fruits, vegetables, whole grains, lean proteins, and healthy fats, can support weight loss and overall reproductive health.
Regular exercise: Engaging in regular physical activity can aid in weight loss, improve insulin sensitivity, and promote hormonal balance. Consult with a healthcare professional to develop an exercise plan suitable for your individual needs.
Lifestyle modifications: Making healthy lifestyle choices such as reducing stress, getting adequate sleep, and avoiding smoking and excessive alcohol consumption can also support weight loss efforts and enhance fertility.
Endocrinology, Reproductive/Infertility
Nutrition
OB/GYN and Women\'s Health
Low body weight can indeed have an impact on female fertility. Maintaining a healthy weight is important for reproductive health, and underweight conditions can affect a woman’s ability to conceive.
Anovulation refers to the absence of ovulation, which is necessary for conception. Low body weight, particularly in cases of extreme or rapid weight loss, can disrupt the normal hormonal signaling required for ovulation to occur.
As a result, women may experience irregular or infrequent ovulation or even a complete absence of ovulation.
Achieve a healthy weight: Focus on reaching a healthy weight range for your height and body type. This often involves gaining weight to achieve a BMI (body mass index) within the normal range (18.5 to 24.9). A healthcare professional can help determine the appropriate target weight for you.
Balanced and nutritious diet: Ensure that your diet provides adequate nutrition to support reproductive health. Include a variety of nutrient-dense foods such as fruits, vegetables, whole grains, lean proteins, and healthy fats. Working with a registered dietitian can be beneficial in creating a well-rounded meal plan that meets your specific needs.
Caloric intake: If you have been under-consuming calories due to low body weight, gradually increase your calorie intake to support weight gain. However, it’s important to do this in a balanced manner and avoid excessive or rapid weight gain, as it can also have negative impacts on fertility.
Exercise moderation: Engage in regular, moderate exercise that supports overall health without excessive strain or intensity. Exercise can help maintain a healthy weight, promote hormonal balance, and enhance fertility. However, excessive exercise or intense training can disrupt menstrual cycles and affect fertility, so it’s important to find a balance that works for you.
Stress management: Chronic stress can impact fertility. Incorporate stress-management techniques such as mindfulness, meditation, yoga, or counseling to help reduce stress levels and support overall well-being.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
clomiphene citrate (Clomid):
Clomid is an oral medication that acts as a selective estrogen receptor modulator (SERM). It blocks estrogen receptors in the hypothalamus, which tricks the body into perceiving low estrogen levels.
As a result, the hypothalamus releases more gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to produce more follicle-stimulating hormone (FSH).
Increased FSH levels encourage the growth and maturation of ovarian follicles, leading to ovulation.
Clomid is commonly used at low doses to induce the growth of a single follicle and promote the release of a single egg.
letrozole (Femara):
letrozole is an oral drug used for ovulation induction. It belongs to a class of drugs called aromatase inhibitors, which work by reducing the production of estrogen. Lower estrogen levels stimulate the hypothalamus to release more GnRH and subsequently increase FSH production.
letrozole has been found to be particularly effective in women with polycystic ovary syndrome (PCOS), making it the first-line choice for ovulation induction in this population.
Letrozole should be prioritized as the primary treatment option for women diagnosed with PCOS instead of clomiphene. The advantages of letrozole compared to clomiphene include.
Studies have shown that Letrozole may have advantages over Clomid in terms of higher ovulation and pregnancy rates in women with PCOS.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
Gonadotropins (Menopur, Gonal-F, Follistim):
Gonadotropins are injectable medications that contain either FSH alone or a combination of FSH and luteinizing hormone (LH). These drugs are more potent than oral agents like Clomid and Letrozole.
Gonadotropins are typically used in cases where Clomid or Letrozole have not been effective or in situations where a higher number of follicles need to be stimulated for superovulation. They can be administered alone or in combination with oral medications.
It involves the use of medications that contain follicle-stimulating hormone (FSH) and luteinizing hormone (LH) to stimulate the ovaries and promote the development and release of eggs.
In a specific study involving normogonadotropic anovulatory women who failed to achieve pregnancy after undergoing six cycles of clomiphene citrate therapy, it was observed that subsequent administration of gonadotropins resulted in a higher rate of live births compared to continuing treatment with clomiphene (52% versus 41%).
Close monitoring is essential when using gonadotropins, usually through ultrasound imaging and estrogen measurements, to assess ovarian response and minimize the risk of complications.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
metformin:
Insulin resistance is frequently observed in females diagnosed with polycystic ovary syndrome (PCOS). Administering metformin to correct hyperinsulinemia proves advantageous for anovulatory women with PCOS, as it promotes improved menstrual regularity and increased likelihood of spontaneous ovulation. Nevertheless, it is worth noting that the success rates in terms of live births are not as remarkable as those achieved with clomiphene
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
Laparoscopic surgery used to diagnose and treat various conditions, including female infertility. It involves making small incisions in the abdomen and inserting a laparoscope—a thin, flexible tube with a camera and surgical instruments—to visualize and operate on the reproductive organs. It helps in identifying Endometriosis, ovarian cysts and Uterine abnormalities.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
Dopamine agonists, such as bromocriptine and cabergoline, are commonly used as the first-line treatment for hyperprolactinemia, including cases associated with pituitary adenomas. These medications work by reducing the production of prolactin, a hormone that can inhibit ovulation and fertility.
The efficacy of dopamine agonists in treating hyperprolactinemia has been well-established. Even in the presence of pituitary adenomas, these drugs have shown effectiveness in reducing prolactin levels and restoring normal ovulatory cycles.
In patients with hyperprolactinemic anovulation, long-term use of dopamine agonists can have positive effects on fertility. By reducing prolactin levels, these medications can help promote the occurrence of spontaneous ovulatory cycles. They can also normalize the luteal phase, which is important for successful implantation and early pregnancy.
Endocrinology, Reproductive/Infertility
OB/GYN and Women\'s Health
In cases of bilateral tubal factor infertility, in vitro fertilization (IVF) is the recommended primary treatment option. Alternative procedures such as tubal corrective surgeries have demonstrated poorer pregnancy outcomes and an elevated risk of ectopic pregnancy. In situations where women experience severe tubal disease, including hydrosalpinx, it is advised to undergo a bilateral salpingectomy to enhance the success rate of IVF and improve the chances of pregnancy. However, for individuals with mild distal tubal disease, fimbrioplasty may be considered as an alternative, enabling multiple pregnancies without the need for IVF.
It is important to note that a small-scale study indicated comparable pregnancy rates to IVF in cases of mild tubal disease, yet there was a significantly higher risk of ectopic pregnancy (15%) compared to the minimal risk (0.7%) associated with IVF treatment.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
